Announcements Trials
Browse Landscape

Status

Unknown 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Prostatic Neoplasms 15Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 2Rhabdoid Tumor 2Wilms Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Neoplasms, Castration-Resistant 1Progressive Metastatic Castrate Resistant Prostate Cancer 1Pinealoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Disease 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Meningeal Neoplasms × Genitourinary × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡